ANIX - Anixa Biosciences Inc
Anixa Biosciences Inc Logo

ANIX - Anixa Biosciences Inc

https://www.anixa.com
Momentum: Bearish
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Downtrend
Source: Snapshot

Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company is headquartered in San Jose, California.

52W High
$4.20
52W Low
$2.07
MA Status:
50D: Below 200D: Below
Beta (~1 neutral, <0.9 lower risk)
0.59
Valuation
As of 2025-04-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
-8.76
EV/Revenue (<3 favorable)
368.98
P/S (TTM) (<3 favorable)
481.54
P/B (<3 favorable)
5.95
Ownership
Retail‑heavy
Source: Overview
Insiders (1–5% typical)
5.43%
Institutions (25–75% balanced)
16.87%
Shares Outstanding
32,211,100
Float
30,462,700
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-04-30 (Overview)
Revenue (TTM)
0
Gross Profit (TTM)
0
EPS (TTM)
-0.38
Profit Margin (>10% good)
N/A
Operating Margin (TTM) (higher better)
N/A
ROE (TTM) (>15% strong)
-0.65%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
N/A
Momentum
Bearish momentum
Value
-0.0362
Previous
-0.0330
Trend
Falling
Signal Cross
No cross
As of
Sep. 12, 2025